ADMS · Categories · Form 4

ADMS - SEC Form 4 insider transactions

Adamas Pharmaceuticals, Inc. (ADMS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ADMS

• 1657d
  SEC Form 4: Bigham Michael closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Mahoney David L closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Prentiss Christopher B was granted 18,750 shares, closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Mcfarlane Neil F. was granted 75,000 shares, closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Ericson William W. closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Shreedhar Vijay was granted 18,750 shares, closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Papapetropoulos Spyridon closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Richo Anna closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Demski Martha J closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1657d
  SEC Form 4: Macphee John A closing all direct ownership in the company

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1811d
  SEC Form 4: Shreedhar Vijay sold $31,983 worth of Common Stock (6,200 units at $5.16), decreasing direct ownership by 4% to 165,735 units (tax withholding)

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1826d
  SEC Form 4: DEMSKI MARTHA J sold $10,340 worth of Common Stock (2,000 units at $5.17), decreasing direct ownership by 20% to 8,000 units (withholding obligation)

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4: RICHO ANNA was granted 5,000 units of Common Stock, increasing direct ownership by 25% to 25,000 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4 filed by Adamas Pharmaceuticals, Inc.

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4: Papapetropoulos Spyridon was granted 5,000 units of Common Stock, increasing direct ownership by 31% to 20,975 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4 filed by Adamas Pharmaceuticals, Inc.

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4 filed by Adamas Pharmaceuticals, Inc.

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4 filed by Adamas Pharmaceuticals, Inc.

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4: BIGHAM MICHAEL was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1830d
  SEC Form 4: DEMSKI MARTHA J was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1903d
  SEC Form 4: Vijay Shreedhar sold $5,780 worth of Common Stock (1,051 units at $5.50), decreasing direct ownership by 0.62% to 169,435 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1903d
  SEC Form 4: B Christopher Prentiss sold $13,273 worth of Common Stock (2,422 units at $5.48), decreasing direct ownership by 2% to 145,017 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1910d
  SEC Form 4: L David Mahoney exercised 48,000 units of Common Stock at a strike of $0.67, increasing direct ownership by 77% to 110,153 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1910d
  SEC Form 4: A John Macphee exercised 192,000 units of Common Stock at a strike of $0.67, increasing direct ownership by 3,840% to 197,000 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1911d
  SEC Form 4: Spyridon Papapetropoulos bought $30,233 worth of Common Stock (5,975 units at $5.06), increasing direct ownership by 60% to 15,975 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1923d
  SEC Form 4: F. Neil Mcfarlane was granted 300,000 units of Common Stock, increasing ownership by 133% to 525,000 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1923d
  SEC Form 4: Vijay Shreedhar was granted 75,000 units of Common Stock, increasing ownership by 79% to 170,486 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1923d
  SEC Form 4: B Christopher Prentiss was granted 75,000 units of Common Stock, increasing ownership by 104% to 147,439 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1953d
  SEC Form 4: B Christopher Prentiss sold $24,302 worth of Common Stock (3,821 units at $6.36), decreasing ownership by 5% to 72,439 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1953d
  SEC Form 4: Vijay Shreedhar sold $28,844 worth of Common Stock (4,514 units at $6.39), decreasing ownership by 5% to 95,486 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)
• 1963d
  SEC Form 4: B Christopher Prentiss sold $11,598 worth of Common Stock (2,630 units at $4.41), decreasing ownership by 3% to 76,260 units

  4 - Adamas Pharmaceuticals Inc (0001328143) (Issuer)

Other ADMS categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends